RecruitingNot ApplicableNCT04912453

Primary Anastomosis Versus Enterostomy in the Surgical Treatment of Necrotising Enterocolitis

A Randomised Controlled Trial to Compare Primary Anastomosis Versus Enterostomy in the Surgical Treatment of Necrotising Enterocolitis


Sponsor

The University of Hong Kong

Enrollment

90 participants

Start Date

Jul 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Necrotizing enterocolitis (NEC) is a devastating disease that affects the intestine of premature infants and is the most common surgical emergency in newborns. It is estimated that up to 10% of premature babies can suffer from this condition. Despite aggressive medical treatment, surgical intervention is necessary in up half of the cases for bowel necrosis or perforation and these often represent the more severe form of the disease. The advances in neonatal intensive care and surgical knowledge have resulted in improved survival rate in recent years. For NEC patients with severe disease (i.e.) those with intestinal perforation or gangrenous bowel not responding to medical therapy, surgery with resection of diseased segments is the treatment of choice. Traditional surgical approach would be to resect the diseased bowel segment with formation of enterostomy. However, in a few advanced centres, primary anastomosis after the resection of diseased bowel segment is practised. Retrospective reports of the primary anastomosis approach have shown that this is also a viable option with no increased rate of peri-operative morbidity. It also has the advantage of avoiding a second operation for enterostomy closure. Nonetheless, prospective studies comparing the two approaches are lacking. The proposed study will fill up the following knowledge gap on what the best surgical option for NEC at laparotomy is. The findings will help guide our practice for NEC patients in the future in order to provide them with the best possible and evidence-based care. In this study, the investigators hypothesize that neonates with major NEC undergoing primary anastomosis after surgical resection is not inferior to neonates who have enterostomy, in terms of peri-operative morbidities. Aim of the study is to compare the short term and medium term outcomes of NEC patients requiring surgical intervention who either receive primary anastomosis or enterostomy creation.


Eligibility

Max Age: 30 Days

Plain Language Summary

Simplified for easier understanding

This study is comparing two surgical approaches for newborns with necrotizing enterocolitis (NEC) — a serious bowel disease — who need emergency surgery. The two approaches are: (1) directly reconnecting the bowel (primary anastomosis) versus (2) creating a temporary opening in the abdomen (enterostomy) to let the bowel heal before reconnecting it. The goal is to find out which approach leads to better outcomes. You may be eligible if: - You are a newborn (neonate) diagnosed with confirmed NEC - Surgical treatment is required You may NOT be eligible if: - The entire bowel is affected (NEC totalis) and the situation is deemed unsalvageable - Multiple bowel segments are gangrenous, requiring more than two reconnection points - The newborn is too unstable during surgery to safely create a stoma or reconnection - The parents do not agree to participate - Final pathology shows the condition was not NEC Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPrimary anastomosis

At laparotomy, the diseased segment of intestine will be resected and the patients will then receive primary anastomosis

PROCEDUREEnterostomy

At laparotomy, the diseased segment of intestine will be resected and the patients will then receive enterostomy


Locations(1)

Department of Surgery, University of Hong Kong

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04912453


Related Trials